Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities

AKINCI B., Koseoglu F. D., Onay H., Yavuz S., ALTAY C., YILDIRIM ŞİMŞİR I., ...Daha Fazla

METABOLISM-CLINICAL AND EXPERIMENTAL, cilt.64, sa.9, ss.1086-1095, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 64 Sayı: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.metabol.2015.06.004
  • Dergi Adı: METABOLISM-CLINICAL AND EXPERIMENTAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1086-1095
  • Anahtar Kelimeler: APL, Diabetes, Hepatic steatosis, Hypertriglyceridemia, Insulin resistance, LEPTIN
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective. Acquired partial lipodystrophy (APL) is a rare disorder characterized by progressive selective fat loss. In previous studies, metabolic abnormalities were reported to be relatively rare in APL, whilst they were quite common in other types of lipodystrophy syndromes.